FDA Inspection 803217 — The Nebraska Medical Center

The Nebraska Medical Center — FEI 3000210077

The FDA completed an inspection of The Nebraska Medical Center on October 19, 2012 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 19, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)